Naar inhoud
Nu

In ontwikkelingDag 1

NSW September unauthorized-peptide emergency visits

  1. Update 1 van 1NieuwsteDag 1

    NSW records 1,180 peptide-linked emergency visits amid warnings on online products

    Fifteen months of NSW surveillance show a sharp rise in emergency presentations associated with peptide use. The warning concerns unapproved products—not every peptide medicine.

    Kijken

    Vroegste bronABC listen

    Wat we eerst wisten

    • 1,180Emergency presentations over fifteen months
    • 5Presentations in July 2025
    • More than 217Presentations in September 2026
    • NSW recorded a sharp rise in emergency presentations associated with peptide use, alongside a ministerial warning about serious harm from unregulated products.

    Toen nog open

    • The surveillance does not identify the products involved, their verified contents, the number of distinct patients or how many suffered lasting injury.

    Waar we op zouden letten

    • Product-specific findings, fuller surveillance definitions and patient outcomes would show more clearly what is driving the increase. No date has been announced for the next surveillance release.

Wie meldde het

Wie meldde het

11 media · 25 bronnen · 1 video

4 van de 11 hadden op dit moment bericht

Wie erbij betrokken is

Wie erbij betrokken is

Organisaties

  • Ministry of Healthministry in New South Wales, Australia
  • Therapeutic Goods Administrationregulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia

Plaatsen

  • New South Wales